Back to top
more

HealthSouth Corporation (HLS)

(Real Time Quote from BATS)

$49.41 USD

49.41
NA

-0.15 (-0.30%)

Updated Dec 29, 2017 04:02 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Brokerage Reports

0 items in cart

Encompass Health Corporation [HLS]

Reports for Purchase

Showing records 1 - 20 ( 41 total )

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 1

12/04/2017

Daily Note

Pages: 6

Healthcare Services: Tax Reform Positive Near Term; Mixed Bag Longer Term

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 2

10/27/2017

Daily Note

Pages: 13

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 3

10/27/2017

Daily Note

Pages: 6

3Q17 Conference Call Notes

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 4

10/27/2017

Company Report

Pages: 8

Consistent Execution Despite Headwinds

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 5

10/27/2017

Daily Note

Pages: 24

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Price: 75.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 6

10/26/2017

Daily Note

Pages: 3

3Q Slightly Ahead Despite Hurricane Headwind

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 7

09/08/2017

Daily Note

Pages: 10

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 8

09/07/2017

Industry Report

Pages: 12

ST and Potential LT Risks from Irma for the Group

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 9

08/02/2017

Daily Note

Pages: 16

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 10

08/01/2017

Daily Note

Pages: 6

2Q17 Conference Call Notes

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 11

08/01/2017

Company Report

Pages: 8

Raising Estimates Slightly, Although Reimbursement Uncertainty Lingers

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 12

08/01/2017

Daily Note

Pages: 12

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 13

07/31/2017

Daily Note

Pages: 3

2Q Ahead and Low-End of Guidance Raised

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 14

07/11/2017

Company Report

Pages: 5

Trimming Estimates Slightly on Rebranding Investment

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 15

07/11/2017

Daily Note

Pages: 5

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 10.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 16

06/15/2017

Daily Note

Pages: 10

Morning Meeting Notes

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 17

06/15/2017

Company Report

Pages: 28

Initiating Coverage with a Sector Weight Rating

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 75.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 18

10/07/2016

Company Report

Pages: 4

Dropping Coverage Due to Analyst Departure

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 19

07/29/2016

Company Report

Pages: 21

Adjusted EBITDA of $204.3M v. cons. $193.5M Driven By Strong Revenue and Lower Salary Expense

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 75.00

Research Provided by a Third Party

Company: Encompass Health Corporation

Industry: Medical - Outpatient and Home Healthcare

Record: 20

07/18/2016

Daily Note

Pages: 40

2Q16 Managed Care and Hospital Preview: Bullish on Hospitals and Neutral to Positive on Insurers for the Quarter

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 75.00

Research Provided by a Third Party
// eof